Ricerca

Celerion and Ricerca Biosciences form The Biosimilars Alliance

Thursday, March 1, 2012 11:23 AM

Lincoln, Neb.-based Celerion, a provider of early-stage drug development solutions, and Ricerca Biosciences, which offer discovery, preclinical and development services, have formed “The Biosimilars Alliance,” focused on preclinical and early clinical assessment of biologics manufactured by a new supplier.

More... »

Crane joins SNBL USA

Monday, November 7, 2011 10:47 AM

More... »

CiToxLAB names director of scientific projects

Wednesday, July 6, 2011 10:09 AM

CiToxLAB, a non-clinical CRO, named Paul C. Barrow director of scientific projects and client consulting.

More... »

Ricerca Biosciences collaborates with Fulcrum Pharma

Friday, March 4, 2011 02:13 PM

Ricerca Biosciences, a preclinical CRO, has partnered with Fulcrum Pharma, an Aptiv Solutions company and a provider of drug development consulting and regulatory services. The collaboration aims to help biopharmaceutical companies move a candidate from development to clinical evaluation more efficiently.

More... »

Numira Biosciences acquires portion of Ricerca Biosciences

Tuesday, March 1, 2011 08:00 AM

Numira Biosciences of Salt Lake City, Utah, a specialty CRO in high-resolution, 3D imaging services and visualization software for the life science market, has acquired the efficacy pharmacology unit of Ricerca Biosciences of Bothell, Wash. The acquisition adds a GLP-compliant facility with a range of laboratory capabilities to Numira, which will be able to offer in-life models and studies, high-resolution quantitative imaging, histology and immunohistochemistry services.

More... »

MDS’ Early-Stage CRO Reborn as Celerion

Monday, March 29, 2010 01:30 PM

Part of MDS’ early-stage contract research organization (CRO), which was sold off in two parts earlier this month, is re-emerging as Celerion, a CRO owned by a group of private investors.

More... »

MDS Completes Sale of Discovery, Preclinical Portion of CRO

Tuesday, March 9, 2010 06:07 AM

MDS completed its sale of the discovery and preclinical business of MDS Pharma Services, the company’s contract research organization (CRO).  Under the terms of the deal, CRO Ricerca Biosciences of Concord, Ohio, acquired facilities in Bothell, Wash.; Lyon, France; and Taipei, Taiwan. Those facilities have 600 employees.

More... »

MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm

Wednesday, February 10, 2010 12:33 PM

MDS announced today plans to divide MDS Pharma Services, the company’s early-stage contract research organization (CRO), and sell it off to two separate companies for undisclosed amounts. The sale transactions are expected to close by April.

More... »

CROs Add New People, Positions

Thursday, December 4, 2008 11:33 AM

Although many companies are reducing headcount at an alarming rate, at least a few contract research organizations (CROs) continue to hire new people and create new positions. This week’s personnel news from around the clinical trial industry:

More... »

Medpace Hires Executive to Open Bioanalytical Lab in Fall

Tuesday, August 5, 2008 08:00 AM

Cincinnati-based Medpace, a global contract research organization (CRO), has hired Yong-Xi Li as Executive Director of its new Medpace Bioanalytical Laboratories. This new laboratory is projected to open in fall of 2008 and will complement services provided by other Medpace research facilities, such as Medpace Clinical Pharmacology and Medpace Reference Laboratories.

More... »